EGM Builders Is the First Customer to Adopt EVO Technology

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

October 29, 2020

EGM Builders, a self-performing general contractor providing construction services in New Jersey and New York, is the first customer to acquire EVO™ units. Launched in August 2020, EVO is the Company’s latest innovation in exoskeleton technology for industrial use. The news was announced today by Ekso Bionics Holdings.

“Physical fatigue can have significant and negative impacts on employees and companies, as it leads to injuries that can have long-term consequences for individuals and reduce productivity,” said Michael Pratt, Vice President at Ekso Bionics. “As a company focused on protecting and enhancing human strength, endurance and mobility, innovating technologies, such as EVO, that reduce fatigue for industrial workers is a priority. With its early adoption of EVO, EGM Builders is demonstrating its own commitment to protecting the well-being of its valued employees.”

EVO, the next generation of Ekso’s upper-body exoskeleton for industrial use, is the world’s most durable, assistive, and naturally-tracking vest of its kind. EVO includes additional technology, based on market feedback, to aid workers with overhead work, reduce fatigue, and lower the risk of shoulder and back muscle strain. EVO offers 5 to 15 pounds of lift assistance in each arm to elevate and alleviate the day-to-day strain on workers across all industries.

“Commercial construction is physically demanding work and maintaining employee physical health is of our utmost importance,” said Michael Espinosa, President & CEO, Partner at EGM Builders. “We are committed to protecting the safety and health of our employees, who are our most valuable asset and critical resource. EVO’s unique technology will allow our dedicated team members to stay safe and comfortable while performing the industry-leading work for which EGM Builders is known. Reducing the risk of workplace injuries is essential for ensuring that we can attract and retain the best industrial construction workers in the region while sustaining the morale that brings out our employees’ dedication to excellence.”



Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.